Walleye Trading
LEGN icon

Walleye Trading’s Legend Biotech LEGN Stock Holding History

Walleye Trading’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$494K Sell
27,300
-8,900
-25% -$170K ﹤0.01% 2599
2025
Q4 		$787K Buy
36,200
+28,500
+370% +$816K ﹤0.01% 2525
2025
Q3 		$251K Buy
7,700
+5,300
+221% +$196K ﹤0.01% 3207
2025
Q2 		$85.2K Sell
2,400
-6,000
-71% -$194K ﹤0.01% 3658
2025
Q1 		$285K Buy
8,400
+100
+1% +$3.59K ﹤0.01% 2873
2024
Q4 		$270K Buy
+8,300
New +$344K ﹤0.01% 3061
2024
Q1 		– Sell
-9,500
Closed -$572K – 5075
2023
Q4 		$572K Buy
9,500
+5,400
+132% +$342K ﹤0.01% 2963
2023
Q3 		$275K Buy
+4,100
New +$285K ﹤0.01% 3412
2023
Q2 		– Sell
-900
Closed -$43.4K – 4944
2023
Q1 		$43.4K Buy
+900
New +$44K ﹤0.01% 4109
2022
Q4 		– Sell
-5,500
Closed -$224K – 5204
2022
Q3 		$224K Buy
+5,500
New +$258K ﹤0.01% 3580

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Walleye Trading's LEGN Position: Q1 2026 in Review

Walleye Trading increased its Legend Biotech (LEGN) stake by 162% in Q1 2026, buying an estimated $150K and bringing the position to 12,744 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Walleye Trading first reported a position in LEGN in Q3 2023 and has held it in 6 quarters since. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Walleye Trading held 12,744 shares of Legend Biotech worth $231K as of Q1 2026.
  • Walleye Trading bought 7,886 Legend Biotech shares in Q1 2026, an estimated $150K.
  • Legend Biotech made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3040 holding.
  • Walleye Trading first reported a position in Legend Biotech in Q3 2023 and has held it in 6 quarters since.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.